相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia A Randomized Clinical Trial
Olivier Hermine et al.
JAMA INTERNAL MEDICINE (2021)
Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia A Randomized Clinical Trial
Carlo Salvarani et al.
JAMA INTERNAL MEDICINE (2021)
Rapid Translation of COVID-19 Preprint Data into Critical Care Practice
Aidan J. C. Burrell et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2021)
Proteinase release from activated neutrophils in mechanically ventilated patients with non-COVID-19 and COVID-19 pneumonia
Seda Seren et al.
EUROPEAN RESPIRATORY JOURNAL (2021)
Repurposed Antiviral Drugs for Covid-19-Interim WHO Solidarity Trial Results
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial
Viviane C. Veiga et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
Protease-antiprotease imbalance in patients with severe COVID-19
Farid Zerimech et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2021)
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19
Anthony C. Gordon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Tocilizumab plus standard care versus standard care in patients in India with moderate to severe COVID-19-associated cytokine release syndrome (COVINTOC): an open- label, multicentre, randomised, controlled, phase 3 trial
Arvinder S. Soin et al.
LANCET RESPIRATORY MEDICINE (2021)
Therapeutic Application of Alpha-1 Antitrypsin in COVID-19
Nadine Krueger et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2021)
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani et al.
LANCET (2021)
A randomised, double-blind, placebo-controlled, pilot trial of intravenous plasma purified alpha-1 antitrypsin for SARS-CoV-2-induced Acute Respiratory Distress Syndrome: a structured summary of a study protocol for a randomised, controlled trial
Natalie L. McEvoy et al.
TRIALS (2021)
Alpha-1 antitrypsin inhibits TMPRSS2 protease activity and SARS-CoV-2 infection
Lukas Wettstein et al.
NATURE COMMUNICATIONS (2021)
Interleukin-6: obstacles to targeting a complex cytokine in critical illness
Oliver J. McElvaney et al.
LANCET RESPIRATORY MEDICINE (2021)
Latent Class Analysis Reveals COVID-19-related Acute Respiratory Distress Syndrome Subgroups with Differential Responses to Corticosteroids
Pratik Sinha et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2021)
Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study
Matthieu Schmidt et al.
INTENSIVE CARE MEDICINE (2021)
Alpha-1 antitrypsin for cystic fibrosis complicated by severe cytokinemic COVID-19
Oliver J. McElvaney et al.
JOURNAL OF CYSTIC FIBROSIS (2021)
Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China
Chaomin Wu et al.
JAMA INTERNAL MEDICINE (2020)
Consequences of Abrupt Cessation of Alpha1-Antitrypsin Replacement Therapy
Oliver J. McElvaney et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Severe Covid-19
David A. Berlin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Alpha1-Antitrypsin Deficiency
Pavel Strnad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Characterization of the Inflammatory Response to Severe COVID-19 Illness
Oliver J. McElvaney et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
Severe immunosuppression and not a cytokine storm characterizes COVID-19 infections
Kenneth E. Remy et al.
JCI INSIGHT (2020)
Cytokine profile in plasma of severe COVID-19 does not differ from ARDS and sepsis
Jennifer G. Wilson et al.
JCI INSIGHT (2020)
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
Jerome Hadjadj et al.
SCIENCE (2020)
Neutrophil extracellular traps infiltrate the lung airway, interstitial, and vascular compartments in severe COVID-19
Coraline Radermecker et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
SARS-CoV-2-triggered neutrophil extracellular traps mediate COVID-19 pathology
Flavio Protasio Veras et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
An inflammatory cytokine signature predicts COVID-19 severity and survival
Diane Marie Del Valle et al.
NATURE MEDICINE (2020)
Immune responses to SARS-CoV-2 infection in hospitalized pediatric and adult patients
Carl A. Pierce et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
IFN-γ is an independent risk factor associated with mortality in patients with moderate and severe COVID-19 infection
Ana Carolina Gadotti et al.
VIRUS RESEARCH (2020)
Acute respiratory distress syndrome
Michael A. Matthay et al.
NATURE REVIEWS DISEASE PRIMERS (2019)
The Biological Effects of Double-Dose Alpha-1 Antitrypsin Augmentation Therapy A Pilot Clinical Trial
Michael A. Campos et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
Glycosylation Repurposes Alpha-1 Antitrypsin for Resolution of Community-acquired Pneumonia
Cormac McCarthy et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
Interleukin-6: designing specific therapeutics for a complex cytokine
Christoph Garbers et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Safety of biweekly alpha(1)-antitrypsin treatment in the RAPID programme
Timm Greulich et al.
EUROPEAN RESPIRATORY JOURNAL (2018)
Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer
Simon A. Jones et al.
NATURE REVIEWS IMMUNOLOGY (2018)
The role of IL-6 in host defence against infections: immunobiology and clinical implications
Stefan Rose-John et al.
NATURE REVIEWS RHEUMATOLOGY (2017)
Acute Respiratory Distress Syndrome
B. Taylor Thompson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Proteolytic Origin of the Soluble Human IL-6R In Vivo and a Decisive Role of N-Glycosylation
Steffen Riethmueller et al.
PLOS BIOLOGY (2017)
Long-term efficacy and safety of α1 proteinase inhibitor treatment for emphysema caused by severe α1 antitrypsin deficiency: an open-label extension trial (RAPID-OLE)
Noel G. McElvaney et al.
LANCET RESPIRATORY MEDICINE (2017)
Diurnal Variation of Circulating Interleukin-6 in Humans: A Meta-Analysis
Gustav Nilsonne et al.
PLOS ONE (2016)
Unusual Acute Sequelae of α1-Antitrypsin Deficiency A Myriad of Symptoms With One Common Cure
Alessandro N. Franciosi et al.
CHEST (2015)
Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial
Kenneth R. Chapman et al.
LANCET (2015)
The Circulating Proteinase Inhibitor α-1 Antitrypsin Regulates Neutrophil Degranulation and Autoimmunity
David A. Bergin et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Cytokine assays: An assessment of the preparation and treatment of blood and tissue samples
Genoveva C. E. Keustermans et al.
METHODS (2013)
Anti-inflammatory and immunomodulatory properties of α1-antitrypsin without inhibition of elastase
Danny Jonigk et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
The size of a pilot study for a clinical trial should be calculated in relation to considerations of precision and efficiency
Julius Sim et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2012)
Serum levels and genotype distribution of α1-antitrypsin in the general population
Ilaria Ferrarotti et al.
THORAX (2012)
Recommendations for Planning Pilot Studies in Clinical and Translational Research
Charity G. Moore et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2011)
Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling
Simon A. Jones et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
α-1 Antitrypsin regulates human neutrophil chemotaxis induced by soluble immune complexes and IL-8
David A. Bergin et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Exploring the role of CT densitometry: a randomised study of augmentation therapy in α1-antitrypsin deficiency
A. Dirksen et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
α-1-Antitrypsin is an endogenous inhibitor of proinflammatory cytokine production in whole blood
Gregory B. Pott et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
Evaluation of a new Sebia isoelectrofocusing kit for alpha(1)-antitrypsin phenotyping with the Hydrasys (R) System
Farid Zerimech et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2008)
Modulation of TNF-α-converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF-α production and facilitates viral entry
Shiori Haga et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress - The framingham heart study
Karla M. Pou et al.
CIRCULATION (2007)
α1-Antitrypsin, old dog, new tricks -: α1-Antitrypsin exerts in vitro anti-inflammatory activity in human monocytes by elevatin cAMP
Sabina M. Janciauskiene et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Signalling role of adipose tissue: adipokines and inflammation in obesity
P Trayhurn et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2005)
Design and analysis of pilot studies: recommendations for good practice
GA Lancaster et al.
JOURNAL OF EVALUATION IN CLINICAL PRACTICE (2004)
Augmentation therapy with α1-antitrypsin -: Patterns of use and adverse events
JK Stoller et al.
CHEST (2003)
Raised interleukin-6 levels in obese patients
L Roytblat et al.
OBESITY RESEARCH (2000)
分享论文
